| GPGI price | $14.29 at the August 3, 2026, 11:42 AM EDT reading, up $1.09 or 8.26% from the $13.20 prior close, within a $13.28 to $14.44 day range, after opening at $13.72 | StockAnalysis.com real-time quote | August 3, 2026 |
| Market capitalization | $4.14 billion, reported by StockAnalysis.com and consistent with $14.29 x 289.86 million shares outstanding | StockAnalysis.com quote and financial_rigor.py verification | August 3, 2026 |
| Shares outstanding | 289.86 million shares outstanding; 289,861,445 shares of Class A common stock as of May 7, 2026, per the Q1 2026 Form 10-Q | Q1 2026 Form 10-Q and StockAnalysis.com statistics | August 3, 2026 |
| Q1 2026 pro forma adjusted net sales | $421.2 million, up 3% year over year | GPGI Q1 2026 press release | May 7, 2026 |
| Q1 2026 pro forma adjusted EBITDA | $82.1 million, down 16% year over year, with a pro forma adjusted EBITDA margin of 19.5%, down 430 basis points | GPGI Q1 2026 press release | May 7, 2026 |
| Q1 2026 GAAP results | GAAP net sales effectively $0 under equity method accounting, GAAP net loss of $235.0 million, and EPS of -$0.87 basic | GPGI Q1 2026 press release and Q1 2026 Form 10-Q | August 3, 2026 |
| CompoSecure Q1 2026 results | Record pro forma net sales of $130.4 million, up 26% year over year, and pro forma adjusted EBITDA of $47.6 million, up 37%, with margin up about 300 basis points to 36.5% | GPGI Q1 2026 earnings call and press release | May 7, 2026 |
| Husky Q1 2026 results | Pro forma adjusted net sales of $290.8 million, down 5% year over year, and pro forma adjusted EBITDA of $38.2 million, down 40%, with margin down about 770 basis points to 13.2% | GPGI Q1 2026 earnings call | May 7, 2026 |
| Husky orders and pipeline | Husky orders fell 16% year over year through the end of March as resin prices spiked, while the pipeline grew 4% in Q1 and 7% year over year through April; virgin PET prices rose about 46% in March and April | GPGI Q1 2026 earnings call | May 7, 2026 |
| Husky deferred revenue detail | Over $20 million in Husky revenue was pushed out of Q1, including about $6 million in customer delivery delays, about $5 million in shipment and logistical delays tied to the Middle East conflict, and about $4 million in delays in customer payments | GPGI Q1 2026 earnings call | May 7, 2026 |
| Husky installed base and mix | About 13,500 installed systems, roughly 35% of revenue from new system sales and 65% from recurring revenue, with the installed base globally diverse | GPGI Q1 2026 earnings call | May 7, 2026 |
| Q2 2026 guidance | Adjusted net sales of $425 million to $475 million and adjusted EBITDA of $105 million to $120 million, with pro forma adjusted EBITDA margins of 24.7% to 25.3% | GPGI Q1 2026 press release | May 7, 2026 |
| FY2026 revised guidance | Pro forma adjusted net sales of $1.95 billion to $2.1 billion, pro forma adjusted EBITDA of $550 million to $610 million, pro forma adjusted free cash flow of $275 million to $325 million, and about 3x year-end net leverage | GPGI Q1 2026 press release | May 7, 2026 |
| FY2025 CompoSecure results | Non-GAAP net sales of about $462 million, up about 10%, and pro forma adjusted EBITDA of about $171 million, up about 24%, with pro forma adjusted EBITDA margin near 36.9% | GPGI Q4 2025 earnings call | March 12, 2026 |
| FY2025 Husky results | Net sales of about $1.57 billion for full year 2025, up 5%, with Q4 2025 net sales of $521 million, up over 6% | GPGI Q4 2025 earnings call | March 12, 2026 |
| GPGI FY2025 GAAP results | GAAP net sales of $59.8 million and GAAP net loss of $136.0 million attributable to GPGI, reflecting the equity method accounting after the Resolute spin-off | GPGI FY2025 Form 10-K | August 3, 2026 |
| Forward valuation | Forward PE of 14.08, PB of 1.23, forward PS of 1.92, and PE ratio not meaningful on negative trailing GAAP earnings | StockAnalysis.com statistics | August 3, 2026 |
| TTM income statement | TTM revenue of about $24,000 under equity method accounting, TTM net loss of $392.51 million, and EPS of -$2.57 | StockAnalysis.com statistics | August 3, 2026 |
| Book value | Equity of $3.12 billion and book value per share of $10.75, with total assets of $3,414.1 million as of March 31, 2026 | Q1 2026 Form 10-Q and StockAnalysis.com balance sheet | August 3, 2026 |
| Cash and debt | GAAP cash of $6.5 million and no GAAP debt at the GPGI parent, while the adjusted consolidated view shows cash of $121.6 million, long-term debt of $2,138.3 million net of deferred financing costs, and $115.1 million of cash and restricted cash held at GPGI Holdings as of March 31, 2026 | GPGI Q1 2026 press release adjusted balance sheet | August 3, 2026 |
| Equity method investment | Carrying value of the equity method investment in GPGI Holdings of $3,133.2 million as of March 31, 2026, with GPGI owning 100% of GPGI Holdings | Q1 2026 Form 10-Q | August 3, 2026 |
| Dividend | Quarterly dividend of $0.0025 per share, about $0.01 annualized for a yield near 0.07%, declared February 3, 2026 and May 6, 2026, with an ex-dividend date of May 18, 2026 | Q1 2026 Form 10-Q and StockAnalysis.com | August 3, 2026 |
| Buyback activity | No shares repurchased in Q1 2026 under the program, which was increased from $40 million to up to $100 million in February 2025; 647,782 shares repurchased in 2025 at a cost of $12.2 million | Q1 2026 Form 10-Q | August 3, 2026 |
| Reincorporation | Stockholders approved the reincorporation from Delaware to Nevada on June 4, 2026, and the conversion became effective on June 5, 2026 | GPGI Form 8-K filings | August 3, 2026 |
| Securities class actions | Securities class actions and investigations announced in 2026, including a Kaplan Fox notice with a lead plaintiff deadline of September 14, 2026, a Bernstein Liebhard class action alert, and RGRD and Grabar Law investigations | Newsfile and GlobeNewswire press releases | August 3, 2026 |
| Q2 2026 earnings date | Q2 2026 earnings call announced on July 23, 2026, with results expected on August 6, 2026 before market open | GPGI Q2 2026 earnings call announcement and StockAnalysis.com | August 3, 2026 |
| Analyst coverage | Two analysts on StockAnalysis.com with a consensus of Buy and an average price target of $20.00, while JPMorgan lowered its target to $15 from $22 with a Neutral rating in May 2026 | StockAnalysis.com statistics and JPMorgan rating action | August 3, 2026 |
| Short interest | 33.75 million shares short, equal to 11.64% of shares outstanding and 23.51% of float, with a short ratio of 18.97 days to cover | StockAnalysis.com statistics | August 3, 2026 |
| 52-week range and performance | 52-week range of $11.22 to $26.78, 52-week price change of -0.29%, and beta of 0.86 | StockAnalysis.com quote and statistics | August 3, 2026 |
| Technical snapshot | 5-day moving average near $13.80, 20-day near $14.41, 50-day near $13.85, 100-day near $14.87, 200-day near $18.12, 14-day RSI near 51.23, 14-day ADX near 17.51, and 14-day historical volatility near 59.90% | Barchart and StockAnalysis.com technical snapshots | August 3, 2026 |
| Scores | Altman Z-Score of 5.29 and Piotroski F-Score of 3 | StockAnalysis.com statistics | August 3, 2026 |